Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1/PHASE2
40 participants
INTERVENTIONAL
2022-06-30
2022-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Curcumin Supplementation for the Improvement of Diabetes-related Outcomes
NCT06984640
Curcumin for Type 2 Diabetic Patients
NCT01052597
Curcumin's Effect on Diabetic Patients With Atherosclerotic Cardiovascular Risk
NCT05753436
Effect of Oral Supplementation With Curcumin on Insulin Sensitivity in Subjects With Prediabetes
NCT03917784
Curcumin Supplementation and Patients With Type 2 Diabetes
NCT02529982
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
There is no additional intervention other than subject's standard diabetes treatment
No interventions assigned to this group
Interventional Group
This group will received additional supplementation of curcumin and virgin coconut oil aside from their standard treatment
Curcumin and virgin coconut oil extract (KurCo Smart)
we give 2 tablets of curcumin and virgin coconut oil extract thrice a day for 30 days and evaluate the result
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Curcumin and virgin coconut oil extract (KurCo Smart)
we give 2 tablets of curcumin and virgin coconut oil extract thrice a day for 30 days and evaluate the result
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signing consent form
Exclusion Criteria
* Multiple organ failure
* History of hypersensitivity reaction to curcumin and virgin coconut oil
* Cancer, renal insufficiency, hematological disease, acute heart failure, chronic liver disease
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitas Sebelas Maret
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Nurhasan Agung Prabowo
M.D.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UNS Hospital
Sukoharjo, Central Java, Indonesia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KurCoSmart
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.